These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7762068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L.
    Kumagai-Braesch M, Ekberg H, Wang F, Osterholm C, Ehrnfelt C, Sharma A, Lindeborg E, Holgersson J, Corbascio M.
    Transplantation; 2007 May 15; 83(9):1259-67. PubMed ID: 17496544
    [Abstract] [Full Text] [Related]

  • 7. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL, Xue WJ, Tian PX, Ding XM, Tian XH, Feng XS, Hou J.
    Transplant Proc; 2007 Dec 15; 39(10):3436-7. PubMed ID: 18089400
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
    Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB.
    J Immunol; 1995 Aug 01; 155(3):1165-74. PubMed ID: 7543517
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
    Levisetti MG, Padrid PA, Szot GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR, Bluestone JA.
    J Immunol; 1997 Dec 01; 159(11):5187-91. PubMed ID: 9548454
    [Abstract] [Full Text] [Related]

  • 10. In situ protection against islet allograft rejection by CTLA4Ig transduction.
    Londrigan SL, Sutherland RM, Brady JL, Carrington EM, Cowan PJ, d'Apice AJ, O'Connell PJ, Zhan Y, Lew AM.
    Transplantation; 2010 Nov 15; 90(9):951-7. PubMed ID: 20808263
    [Abstract] [Full Text] [Related]

  • 11. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
    Lakkis FG, Konieczny BT, Saleem S, Baddoura FK, Linsley PS, Alexander DZ, Lowry RP, Pearson TC, Larsen CP.
    J Immunol; 1997 Mar 01; 158(5):2443-8. PubMed ID: 9036995
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
    Potiron N, Chagneau C, Boeffard F, Soulillou JP, Anegon I, Le Mauff B.
    Cell Transplant; 2005 Mar 01; 14(5):263-75. PubMed ID: 16052908
    [Abstract] [Full Text] [Related]

  • 13. Combined costimulation blockade prevents rejection of allogeneic islets in mice.
    Malm H, Påhlman C, Veress B, Corbascio M, Ekberg H.
    Scand J Immunol; 2006 Oct 01; 64(4):398-403. PubMed ID: 16970681
    [Abstract] [Full Text] [Related]

  • 14. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.
    Uchikoshi F, Yang ZD, Rostami S, Yokoi Y, Capocci P, Barker CF, Naji A.
    Diabetes; 1999 Mar 01; 48(3):652-7. PubMed ID: 10078573
    [Abstract] [Full Text] [Related]

  • 15. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 16. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice.
    Zhang J, Li H, Jiang N, Zhang Q, Wang GS, Yi HM, Fu BS, Wang GY, Yang Y, Chen GH.
    Transplant Proc; 2010 Jun 15; 42(5):1835-7. PubMed ID: 20620534
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
    Akamaru Y, Ito T, Uchikoshi F, Maeda A, Tori M, Kiyomoto T, Komoda H, Miao G, Matsuda H.
    Transpl Immunol; 2003 Jun 15; 11(1):91-100. PubMed ID: 12727480
    [Abstract] [Full Text] [Related]

  • 18. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
    Lew AM, Brady JL, Silva A, Coligan JE, Georgiou HM.
    Transplantation; 1996 Jul 15; 62(1):83-9. PubMed ID: 8693551
    [Abstract] [Full Text] [Related]

  • 19. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
    Honkanen-Scott M, Johnson J, Hering B, Bansal-Pakala P.
    Transplant Proc; 2008 Mar 15; 40(2):483-5. PubMed ID: 18374109
    [Abstract] [Full Text] [Related]

  • 20. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
    Newell KA, He G, Guo Z, Kim O, Szot GL, Rulifson I, Zhou P, Hart J, Thistlethwaite JR, Bluestone JA.
    J Immunol; 1999 Sep 01; 163(5):2358-62. PubMed ID: 10452966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.